StonvexLoading…
StonvexStonvexStonvexCore line items from CMG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.93B | $11.31B | $9.87B | $8.63B |
Operating Income | $1.94B | $1.92B | $1.56B | $1.16B |
Net Income | $1.54B | $1.53B | $1.23B | $899.10M |
EPS (Diluted) | $1.14 | $1.11 | $0.89 | $0.64 |
Total Assets | $8.99B | $9.20B | $8.04B | $6.93B |
Total Liabilities | $6.16B | $5.55B | $4.98B | $4.56B |
Cash & Equivalents | $350.55M | $748.54M | $560.61M | $384.00M |
Free Cash Flow OCF − CapEx | $1.45B | $1.51B | $1.22B | $844.01M |
Shares Outstanding | 1.34B | 1.38B | 1.39B | 1.40B |